Profound central depression during treatment of tetanus with combined magnesium, midazolam, morphine and fentanyl | Zendy

R.M.M.K. Namal Rathnayaka | Zendy; Janaka Ranaweera | Zendy; P Palihakkara | Zendy; P.E. Anusha Nishanthi Ranathunga | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Profound central depression during treatment of tetanus with combined magnesium, midazolam, morphine and fentanyl

Author(s) -

R.M.M.K. Namal Rathnayaka,

Janaka Ranaweera,

P Palihakkara,

P.E. Anusha Nishanthi Ranathunga

Publication year - 2015

Publication title -

sri lankan journal of anaesthesiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.145

H-Index - 4

eISSN - 2279-1965

pISSN - 1391-8834

DOI - 10.4038/slja.v23i2.8077

Subject(s) - medicine , midazolam , fentanyl , sri lanka , audit , depression (economics) , anesthesia , sedation , macroeconomics , economics , ethnology , management , south asia , history

A 61year old male patient with generalized tetanus developed central depression due to combined use of magnesium sulphate, midazolam, morphine and fentanyl. He was successfully treated with magnesium sulphate (MgSO 4 ) infusion with the minimal usage of sedatives and paralytic agents. Lowering of GCS occurred on day 6, 7 and 8 indicating central depression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research